Square-C

Kvadrat-C is a Russian manufacturer of dietary supplements (dietary supplements) such as premium curcumin, vitamins K2 and D, glutamic acid, and alkodetox. By October 2021, the company's portfolio includes about 220 products.

History

2025: Launch of a dietary supplement plant in the Moscow Region

Kvadrat-S, one of the leading manufacturers of dietary supplements in Russia, opened production in the village of Obolensk, Moscow Region, in February 2025. The capacity of the new enterprise is 7 million packs of dietary supplements per year.

According to the Industrial Development Fund (FRP), the company has invested ₽223 million in the creation of a production site. The company produces products in various forms: hard gelatin capsules in cans and blisters, sachets, sticks and strips. The level of localization of production exceeds 50%.

𝓲

Фото: Freepik

The range of products is sold under the brands "Vitamir" and Tetralab through:

• Pharmaceutical distributors.
• Pharmacy chains.
• Remote ordering services (apteka.ru, zdravcity.ru).
• Marketplaces (Ozone, Wildberry, Yandex.Market).

Oleg Komarov, manager of Kvadrat-S LLC, said: "Over the past three years, we have invested serious funds in the development of production. A significant part of which was received through the Industrial Development Fund. As a result, the total capacity of the enterprise for the production of biologically active additives, which includes sites in the Moscow and Kirov regions, will increase by 70% - to 53 million packages per year. "

The company plans to further expand production in Obolensk. The new workshop will increase production from 7 to 22 million packages per year. The company also intends to master the production of dietary supplements in new forms - in drops and soft gelatin capsules.

To implement the expansion plans, Kvadrat-S received a second preferential loan from the FRP in the amount of ₽608,5 million. The total investment in the new development project will exceed ₽760 million.

At the end of 2023, the company has already opened a similar production in the urban-type village of Vostochny, Kirov Region. The total investment in the creation of two production sites amounted to ₽790 million, including a preferential loan of FRP under the Development Projects program in the amount of ₽231 million.^[1]

2021: Baring Vostok bought 16% of Kvadrat-C

In early October 2012, it became known about the sale of 16% of Kvadrat-S to the Baring Vostok investment fund. Its participants did not disclose the financial terms of the transaction. According to Vedomosti, citing a source close to one of the parties to the transaction, we are talking about an amount of 2 billion rubles.

The newspaper cites data from the SPARK-Interfax system, according to which in mid-September 2021, the Cypriot company Oxalys Limited became the owner of the 16% stake in Kvadrat S LLC. It, in turn, belongs to Baring Vostok.

By the beginning of October 2021, the largest owner of Kvadrat-S is Ekaterina Vavilova, which owns 37.4%.

Baring Vostok acquired 16% of Kvadrat-C

Kvadrat-S intends to spend the funds raised on expanding production capacities. By the beginning of October 2021, the company can produce about 50 million packages per year. With the launch of a new production at the end of 2022, the company will be able to produce a similar volume.

Baring Vostok explained the purchase of Quadras-S by the growth of the Russian dietary supplement market caused by the COVID-19 coronavirus pandemic. The Fund expects that in the future, Kvadrat-S products will be able to successfully replace expensive imported analogues.

According to DSM Group estimates, sales of these products in Russian pharmacies at the end of 2020 increased by 17.1% compared to 2019 - to 74.1 billion rubles. In 2021, restrictions on online trading of dietary supplements were lifted, so in the future the growth rate will accelerate, said Sergei Shulyak, head of DSM Group.^[2]

Notes